1. Alternative access schemes for pharmaceuticals in Europe: towards an emerging typology;Löblová;Health Policy,2019
2. Do patient access schemes for high-cost cancer drugs deliver value to society?-Lessons from the NHS cancer drugs fund;Aggarwal;Annals of Oncology,2017
3. NHS England. NHS England » Individual requests for funding n.d. https://www.england.nhs.uk/contact-us/privacy-notice/how-we-use-your-information/our-services/individual-requests-for-funding/ (accessed December 12, 2018).
4. Early access programs: benefits, challenges, and key considerations for successful implementation;Patil;Perspectives in Clinical Research,2016
5. Unlicensed and off-label uses of medicines: definitions and clarification of terminology;Aronson;British Journal of Clinical Pharmacology,2017